TGF‐β–responsive CAR‐T cells promote anti‐tumor immune function

A chimeric antigen receptor (CAR) that responds to transforming growth factor beta (TGF‐β) enables the engineering of T cells that convert this immunosuppressive cytokine into a potent T‐cell stimulant. However, clinical translation of TGF‐β CAR‐T cells for cancer therapy requires the ability to pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Andrew J., Chang, ZeNan L., Lorenzini, Michael H., Zah, Eugenia, Chen, Yvonne Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063867/
https://www.ncbi.nlm.nih.gov/pubmed/30065964
http://dx.doi.org/10.1002/btm2.10097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063867/
https://www.ncbi.nlm.nih.gov/pubmed/30065964
http://dx.doi.org/10.1002/btm2.10097

Ejemplares similares